183 related articles for article (PubMed ID: 10918571)
1. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt.
Hakak Y; Hsu YS; Martin GS
Oncogene; 2000 Jun; 19(28):3164-71. PubMed ID: 10918571
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
3. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis.
Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM
J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005
[TBL] [Abstract][Full Text] [Related]
4. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
5. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
6. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
Kapoor GS; Zhan Y; Johnson GR; O'Rourke DM
Mol Cell Biol; 2004 Jan; 24(2):823-36. PubMed ID: 14701753
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
[TBL] [Abstract][Full Text] [Related]
8. Cas mediates transcriptional activation of the serum response element by Src.
Hakak Y; Martin GS
Mol Cell Biol; 1999 Oct; 19(10):6953-62. PubMed ID: 10490632
[TBL] [Abstract][Full Text] [Related]
9. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
Holgado-Madruga M; Wong AJ
Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
[TBL] [Abstract][Full Text] [Related]
10. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Tang H; Zhao ZJ; Landon EJ; Inagami T
J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells.
Carlberg K; Rohrschneider LR
J Biol Chem; 1997 Jun; 272(25):15943-50. PubMed ID: 9188495
[TBL] [Abstract][Full Text] [Related]
12. The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase.
Fincham VJ; Brunton VG; Frame MC
Mol Cell Biol; 2000 Sep; 20(17):6518-36. PubMed ID: 10938128
[TBL] [Abstract][Full Text] [Related]
13. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
14. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.
Cuevas B; Lu Y; Watt S; Kumar R; Zhang J; Siminovitch KA; Mills GB
J Biol Chem; 1999 Sep; 274(39):27583-9. PubMed ID: 10488096
[TBL] [Abstract][Full Text] [Related]
15. Fyn kinase-directed activation of SH2 domain-containing protein-tyrosine phosphatase SHP-2 by Gi protein-coupled receptors in Madin-Darby canine kidney cells.
Tang H; Zhao ZJ; Huang XY; Landon EJ; Inagami T
J Biol Chem; 1999 Apr; 274(18):12401-7. PubMed ID: 10212213
[TBL] [Abstract][Full Text] [Related]
16. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells.
You M; Zhao Z
J Biol Chem; 1997 Sep; 272(37):23376-81. PubMed ID: 9287352
[TBL] [Abstract][Full Text] [Related]
17. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
18. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway.
Krautwald S; Büscher D; Kummer V; Buder S; Baccarini M
Mol Cell Biol; 1996 Nov; 16(11):5955-63. PubMed ID: 8887625
[TBL] [Abstract][Full Text] [Related]
20. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase.
Marti F; Xu CW; Selvakumar A; Brent R; Dupont B; King PD
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11810-5. PubMed ID: 9751747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]